{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002418","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"EGAX00001365841","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_ANTIBODY":["H3K4me3"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["194"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor NGS (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"548M","NAME":"S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160226.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160226.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"768948aade1a8a5f8d5ecc99679cb71e"},{"FORMAT":"bigBed","SIZE":"909K","NAME":"S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160527.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160527.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"796c85c673d583669244d4260d94b7e3"},{"FORMAT":"BED","SIZE":"1019K","NAME":"S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160527.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160527.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"c816e6efc44b41cc1f169db10a85b46c"},{"FORMAT":"Text","SIZE":"1.2M","NAME":"S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160527.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1305351.H3K4me3.bwa.GRCh38.20160527.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"f5d12c796554a158ec09223eb4933f9b"}],"dataset_id":"EGAD00001002418","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"S01RFW","sample_barcode":"S01RFWH1","attributes":{"DONOR_HEALTH_STATUS":["Acute Myeloid Leukemia"],"DONOR_AGE":["0 - 18"],"MOLECULE":["genomic DNA"],"DISEASE":["Acute Myeloid Leukemia"],"BIOMATERIAL_PROVIDER":["Anke Bergmann"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C0023467"}],"SUBJECT_ID":["S01RFW"],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["unknown"],"DONOR_ID":["S01RFW"],"DONOR_SEX":["Unknown"],"SEX":["unknown"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001360033","SAMPLE_DESCRIPTION":"Acute Myeloid Leukemia"}}